InVivo Therapeutics Holdings Corporation (NVIV) Research

InVivo Therapeutics Holdings Corp. is a biotechnology and biomaterials firm, actively involved in research and clinical development. The company specializes in creating and bringing to market innovative biopolymer scaffolding devices designed to address spinal cord injuries (SCI). Its primary investigational product is the Neuro-Spinal Scaffold implant, a bioresorbable polymer scaffold. This device is engineered to be implanted directly at the site of injury within the spinal cord, aiming to treat acute SCI. Established in 2003, the company maintains its headquarters in Cambridge, Massachusetts.

Market snapshot

Symbol
NVIV
Price
$0.32
Day change
-34.28%
Market cap
$995.9K
P/E ratio
-0.05x
52-week range
0.22-2.4
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Accelerate Diagnostics, Inc. (AXDX)
  • Bellicum Pharmaceuticals, Inc. (BLCM)
  • CohBar, Inc. (CWBR)
  • Altamira Therapeutics Ltd. (CYTO)
  • HTG Molecular Diagnostics, Inc. (HTGMQ)
  • Impel Pharmaceuticals Inc. (IMPL)
  • Infinity Pharmaceuticals, Inc. (INFIQ)
  • Lucy Scientific Discovery Inc. (LSDI)

Recent insider activity

  • Foose Brice — S-Sale (37000 shares) on 2023-02-05
  • Foose Brice — S-Sale (20000 shares) on 2023-02-05
  • Foose Brice — S-Sale (13000 shares) on 2023-02-05
  • Foose Brice — S-Sale (48000 shares) on 2023-02-05
  • Foose Brice — S-Sale (12000 shares) on 2023-02-05

Open InVivo Therapeutics Holdings Corporation (NVIV) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.